Latest Breaking News On - Azfar zaman - Page 1 : comparemela.com

SMT Sahajanand Medical Technologies a pioneering healthcare company in India with a focus on innovative patient care in the cardiovascular sector is pleased to announce promising data from its study the Prospective SFLEX UKII Registry.

United kingdomSan franciscoUnited statesNewcastle upon tyneAzfar zamanKrishna sudhirSupraflex cruzSahajanand medical technologiesTotal durationTarget lesion failureFreeman hospitalUnited kingdom principal investigatorMedical officer dr krishna sudhirSmt sahajanand medical technologies healthcare company cardiovascular sector sflex ukii registry innovative patient care dr krishna sudhir sirolimuseluting stents ses supraflex cruz stent implantation prof azfar zaman target lesion failure tlf thrombosis